Literature DB >> 9049838

Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line.

L Campagnolo1, M Giorgi, G Augusti-Tocco.   

Abstract

The effects of cyclic nucleotide phosphodiesterase (PDE) inhibitors on cell proliferation of SK-N-MC human neuroepithelioma cell line was studied. Clonal density experiments in the presence of 100 microM rolipram and zaprinast showed respectively 27% and 91% inhibition. The effects of PDE inhibitors were then investigated on crude cell extracts; the calculated IC50 were 32 microM for zaprinast and 16 nM for DC-TA-46; the latter inhibitor was used instead of rolipram for its higher efficacy. Dose-response experiments in clonal density conditions showed IC50 of 5 microM and 1.8 microM in the presence respectively of zaprinast and rolipram. These data show that both inhibitors are effective in reducing cell growth, although the response was quantitatively different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049838     DOI: 10.1023/a:1005758103118

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

Review 1.  Role of cyclic nucleotides in cell growth and differentiation.

Authors:  D L Friedman
Journal:  Physiol Rev       Date:  1976-10       Impact factor: 37.312

Review 2.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

Authors:  J A Beavo; D H Reifsnyder
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

3.  Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by the phosphodiesterase inhibitor isobutylmethylxanthine.

Authors:  P Janik; A Assaf; J S Bertram
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

Review 4.  Molecular and lectin probe analyses of neuronal differentiation.

Authors:  S Denis-Donini; A Augusti-Tocco
Journal:  Curr Top Dev Biol       Date:  1980       Impact factor: 4.897

5.  Stimulation of tyrosine hydroxylase activity in an adrenergic clone of mouse neuroblastoma by dibutyryl cyclic AMP.

Authors:  E Richelson
Journal:  Nat New Biol       Date:  1973-04-11

6.  Direct effects of the pyrimido-pyrimidine derivative RA 233 (Rapenton) on rat 13762NF mammary tumor cell clones in vitro.

Authors:  R B Lichtner; T J Goka; R W Butcher; G L Nicolson
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

Review 7.  Regulation and function of cyclic nucleotides.

Authors:  J K Bentley; J A Beavo
Journal:  Curr Opin Cell Biol       Date:  1992-04       Impact factor: 8.382

8.  Inhibition by cAMP of Ras-dependent activation of Raf.

Authors:  S J Cook; F McCormick
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.

Authors:  M Drees; R Zimmermann; G Eisenbrand
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

10.  Neuron specific protein (NSP) in neuroblastoma cells: relation to differentiation.

Authors:  P J Marangos; F K Goodwin; A Parma; C Lauter; E Trams
Journal:  Brain Res       Date:  1978-04-21       Impact factor: 3.252

View more
  3 in total

1.  Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility.

Authors:  K Murata; T Sudo; M Kameyama; H Fukuoka; M Muka; Y Doki; Y Sasaki; O Ishikawa; Y Kimura; S Imaoka
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors.

Authors:  M Giorgi; C Leonetti; G Citro; G Augusti-Tocco
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

Review 3.  Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma.

Authors:  Mara Massimi; Federica Ragusa; Silvia Cardarelli; Mauro Giorgi
Journal:  Cells       Date:  2019-11-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.